- Alder BioPharmaceuticals (NASDAQ:ALDR), which tumbled 17% today on news of a planned equity offering, has regained 1.2% after hours as it prices the sale.
- It's offering 15M shares of common stock at $10/share. The stock closed at $10.12 today, down from yesterday's $12.20.
- The offering was expanded from a planned 12.5M shares. Underwriters also have a greenshoe option to buy up to 2.25M more shares.
Alder BioPharmaceuticals prices offering at $10/share
Recommended For You
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ALDR | - | - |
| Alder BioPharmaceuticals, Inc. | ||